[Diagnosis and therapy for mixed connective tissue diseases].
Yoshinori
Y
Nonomura
Nobuyuki
N
Miyasaka
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000974:Antibodies, Antinuclear; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D011464:Epoprostenol / Q000627:therapeutic use; D005260:Female; D006801:Humans; D006976:Hypertension, Pulmonary; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008297:Male; D008947:Mixed Connective Tissue Disease / Q000175:diagnosis* / Q000276:immunology / Q000503:physiopathology / Q000628:therapy*; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D011928:Raynaud Disease; D012017:Referral and Consultation; D017412:Ribonucleoprotein, U1 Small Nuclear / Q000276:immunology; D013577:Syndrome; D014810:Vitamin E / Q000627:therapeutic use
D000893:Anti-Inflammatory Agents; D000974:Antibodies, Antinuclear; D002121:Calcium Channel Blockers; D007166:Immunosuppressive Agents; D010975:Platelet Aggregation Inhibitors; D017412:Ribonucleoprotein, U1 Small Nuclear; D014810:Vitamin E; D011464:Epoprostenol